Back to mobile site

More on LEXX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (7/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lexaria Bioscience (NQ:LEXX)
Delayed: 0.57 +0.04 (7.55%)
Prev. Close $0.53  
Open$0.58 
52 Wk High$ 
52 Wk Low$ 
Day High$0.58 
Day Low$0.56 
P/E N/A  
EPS$ 
Volume14,173 

Friends, Peers and Foes (?): LEXXW (more...)

Jun 25, 2026 09:10 AM Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Jun 23, 2026 09:25 AM Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
Jun 17, 2026 09:26 AM GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand
Jun 9, 2026 09:25 AM Lexaria begins animal study on next-generation GLP-1 drugs
Jun 9, 2026 09:25 AM Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
Jun 3, 2026 09:25 AM Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
May 19, 2026 09:15 AM Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
May 7, 2026 09:26 AM Lexaria Bioscience Releases Second Episode of Investor Video Series
May 5, 2026 09:11 AM Lexaria advances human study testing oral semaglutide formulations
May 5, 2026 09:10 AM Lexaria Updates Progress on Human Study #7
View All Articles

Entities mentioned with LEXX

View All Entities